Animal Model for Prodromal Parkinson’s Disease

DOI IR (HANDLE) HANDLE Web Site PubMed 4 Citations 73 References Open Access

Bibliographic Information

Published
2020-03-02
Resource Type
journal article
Rights Information
  • © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
DOI
  • 10.3390/ijms21061961
Publisher
MDPI AG

Search this article

Description

Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and subsequent motor symptoms, but various non-motor symptoms (NMS) often precede motor symptoms. Recently, NMS have attracted much attention as a clue for identifying patients in a prodromal stage of PD, which is an excellent point at which to administer disease-modifying therapies (DMTs). These prodromal symptoms include olfactory loss, constipation, and sleep disorders, especially rapid eye movement sleep behavior disorder (RBD), all of which are also important for elucidating the mechanisms of the initiation and progression of the disease. For the development of DMTs, an animal model that reproduces the prodromal stage of PD is also needed. There have been various mammalian models reported, including toxin-based, genetic, and alpha synuclein propagation models. In this article, we review the animal models that exhibit NMS as prodromal symptoms and also discuss an appropriate prodromal model and its importance for the development of DMT of PD.

Journal

Citations (4)*help

See more

References(73)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top